CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleMarket cap is $255.6M, lower than 95% of all stocks globally
- PositionPrice-to-book is 0.87×, lower than 95% of its Biotechnology peers (median 2.97×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.72BCNY255.60M · vs all stocks (USD)
Revenue (TTM)
530.52MCNY78.68M · vs all stocks (USD)
Profit Margin
-9.95%vs Biotechnology peers
Beta
0.3190xvs all stocks
52-Week Change
7.98%vs all stocks
Market Capitalization
1.72BCNY255.60M · vs all stocks (USD)
Enterprise Value
1.83BCNY270.76M · vs all stocks (USD)
Price to Sales (TTM)
3.19xvs Biotechnology peers
Price to Book (MRQ)
0.8714xvs Biotechnology peers
Enterprise to Revenue
3.44xvs Biotechnology peers
Enterprise to EBITDA
26.65xvs Biotechnology peers
Gross Margin
47.90%vs Biotechnology peers
Profit Margin
-9.95%vs Biotechnology peers
Operating Margin
-7.30%vs Biotechnology peers
Return on Assets (TTM)
-1.26%vs Biotechnology peers
Return on Equity (TTM)
-2.70%vs Biotechnology peers
Revenue (TTM)
530.52MCNY78.68M · vs all stocks (USD)
Revenue per Share (TTM)
1.67CNYUpdated Aug 19, 2026Quarterly Revenue Growth
14.20%vs Biotechnology peers
Gross Profit (TTM)
246.99MCNY36.63M · vs all stocks (USD)
EBITDA (TTM)
98.40MCNY14.59M · vs all stocks (USD)
Net Income (TTM)
-52.79MCNY-7.83M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-21.15%vs Biotechnology peers
Operating Cash Flow (TTM)
12.27MCNY1.82M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
46.66MCNY6.92M · vs all stocks (USD)
Payout Ratio
0.00%vs Biotechnology peers
Minority Interest (Equity)
7.62MCNYFY2025 · Dec 31, 2025Revenue
514.09MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
261.59MCNYFY2025 · Dec 31, 2025Gross Profit
252.50MCNYFY2025 · Dec 31, 2025Operating Income
-38.23MCNY-5.67M · vs all stocks (USD)
Pre-tax Income
-61.83MCNYFY2025 · Dec 31, 2025Income Tax Expense
-5.82MCNYFY2025 · Dec 31, 2025Net Income
-56.01MCNYFY2025 · Dec 31, 2025EBIT
-50.58MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
98.40MCNYFY2025 · Dec 31, 2025Research & Development
22.32MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
185.50MCNYFY2025 · Dec 31, 2025Other Operating Expenses
19.97MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.19MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
11.25MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1743CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1743CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
317.98MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
317.98MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-56.01MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
588.64KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-28.77MCNYFY2025 · Dec 31, 2025Free Cash Flow
-49.87MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
280.45MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-56.01MCNYFY2025 · Dec 31, 2025Other Non-cash Items
15.76MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
16.41MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-4.93MCNYFY2025 · Dec 31, 2025Capital Expenditures
-21.10MCNYFY2025 · Dec 31, 2025Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-1.31MCNYFY2025 · Dec 31, 2025Sale of Investments
182.76KCNYFY2025 · Dec 31, 2025Other Investing Activity
5.81MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-16.41MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
159.30MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-155.78MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-14.97MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.33MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-12.79MCNYFY2025 · Dec 31, 2025Shares Outstanding
318.00MSharesUpdated Aug 19, 2026Float Shares
317.84MSharesUpdated Aug 19, 2026% Held by Insiders
47.16%vs all stocks
% Held by Institutions
0.00%vs all stocks
Total Cash (MRQ)
266.13MCNY39.47M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.8370CNYUpdated Aug 19, 2026Total Debt (MRQ)
383.03MCNY56.80M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1965xvs Biotechnology peers
Current Ratio (MRQ)
1.29xvs Biotechnology peers
Book Value per Share (MRQ)
6.11CNYUpdated Aug 19, 2026Total Assets
2.64BCNY392.11M · vs all stocks (USD)
Total Current Assets
679.65MCNYFY2025 · Dec 31, 2025Total Liabilities
685.37MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.96BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
269.70MCNYFY2025 · Dec 31, 2025Total Current Liabilities
415.66MCNYFY2025 · Dec 31, 2025Cash
280.47MCNYFY2025 · Dec 31, 2025Cash Equivalents
252.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
280.47MCNYFY2025 · Dec 31, 2025Accounts Receivable
112.96MCNYFY2025 · Dec 31, 2025Inventory
101.31MCNYFY2025 · Dec 31, 2025Accounts Payable
48.07MCNYFY2025 · Dec 31, 2025Short-term Debt
220.84MCNYFY2025 · Dec 31, 2025Other Current Liabilities
8.41MCNYFY2025 · Dec 31, 2025Long-term Debt
138.37MCNYFY2025 · Dec 31, 2025Common Stock (Book)
318.00MCNYFY2025 · Dec 31, 2025Retained Earnings
83.58MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.96BCNY290.47M · vs all stocks (USD)
Treasury Stock
0.00CNYFY2025 · Dec 31, 202552-Week Low
4.32CNYUpdated Aug 19, 202652-Week High
5.81CNYUpdated Aug 19, 202652-Week Change
7.98%vs all stocks
Beta
0.3190xvs all stocks
50-Day MA
4.94CNYUpdated Aug 19, 2026200-Day MA
5.10CNYUpdated Aug 19, 2026Avg 10-Day Volume
2.49MSharesUpdated Aug 19, 2026Avg 30-Day Volume
2.29MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.1700CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.87×, lower than 95% of its Biotechnology peers (median 2.97×)Notable
Price-to-book: 0.87Industry median: 2.97Industry P5: 1.03Peers compared: 261
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.48Profit Margin: -0.10
Financial Health
Altman Z-Score 1.8: grey zoneSignificant
Altman Z-Score: 1.80
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Market cap is $255.6M, lower than 95% of all stocks globallySignificant
Market cap (USD): 255,603,948Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Surrozen, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Guangdong Jiaying Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Niagen Bioscience Inc.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Fischer Medical Ventures Ltd
Tier 1ProductionApproval-Gated PipelineFlowRule
Hunan Nucien Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Daito Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
TriSalus Life Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Siga Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ginwa Enterprise Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Senseonics Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule